Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» eczema
eczema
FDA approves Eli Lilly's drug for eczema
Reuters
Mon, 09/16/24 - 10:16 pm
Eli Lilly
FDA
eczema
Ebgylss
Lilly's lebrikizumab, delayed at FDA, clears eczema in people with skin of color
Fierce Biotech
Mon, 03/11/24 - 05:11 pm
Eli Lilly
eczema
lebrikizumab
FDA
Apogee data hint at potential for long-lasting eczema drug
BioPharma Dive
Tue, 03/5/24 - 11:33 am
Apogee Therapeutics
clinical trials
eczema
APG777
Eying Incyte's Opzelura, Leo Pharma shares data for JAK cream in hand eczema
Fierce Pharma
Sun, 10/15/23 - 11:52 pm
LEO Pharma
delgocitinib
clinical trials
eczema
hand eczema
FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues
BioSpace
Mon, 10/2/23 - 10:36 am
Eli Lilly
lebrikizumab
atopic dermatitis
eczema
FDA
drug manufacturing
Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications
Fierce Biotech
Tue, 06/27/23 - 10:09 am
Sanofi
clinical trials
eczema
Kymab
amlitelimab
Aslan sells Japanese rights to would-be Dupixent rival for $12M
Fierce Biotech
Thu, 06/22/23 - 10:41 pm
Aslan
Dupixent
Japan
eczema
Sanofi
Regeneron
eblasakimab
Eli Lilly unveils new data from atopic dermatitis therapy trials
Clinical Trials Arena
Tue, 05/2/23 - 10:22 am
Eli Lilly
clinical trial
eczema
atopic dermatitis
lebrikizumab
Leo Pharma announces positive results for hand eczema study
Pharmaphorum
Mon, 02/13/23 - 10:23 am
LEO Pharma
clinical trials
eczema
chronic hand eczema
delgocitinib
One down, one to go: Arcutis' repurposed AstraZeneca drug clears first PhIII eczema trial
Endpoints
Tue, 11/15/22 - 06:35 pm
Arcutis Biotherapeutics
eczema
clinical trials
roflumilast
Despite recent progress, Incyte still far off from pricing goal for key eczema launch Opzelura
Fierce Pharma
Tue, 11/1/22 - 06:59 pm
Inctye
Opzelura
eczema
Pfizer discards eczema, NASH and breast cancer programs in early-phase clean-out
Fierce Biotech
Tue, 11/1/22 - 12:09 pm
Pfizer
R&D
NASH
breast cancer
eczema
Incyte's Opzelura slapped with vitiligo delay amid topical JAK's eczema launch
Fierce Pharma
Mon, 03/14/22 - 11:37 pm
Incyte
Opzelura
eczema
vitiligo
Novartis JAKs in rival to Incyte's topical eczema drug after seeing clinical data
Fierce Biotech
Wed, 02/2/22 - 10:59 am
Novartis
Incyte
JAK inhibitors
Opzelua
eczema
atopic dermatitis
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA
Fierce Pharma
Fri, 01/28/22 - 11:47 am
Eli Lilly
Incyte
olumiant
FDA
lupus
eczema
Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 12/17/21 - 10:52 am
Connect Biopharma
Dupixent
China
eczema
clinical trials
Sanofi, Regeneron plot Dupixent filing in young eczema patients, advancing drug's megablockbuster ambitions
Fierce Pharma
Mon, 12/13/21 - 11:04 am
Sanofi
Regeneron
Dupixent
eczema
pediatric
Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 11/19/21 - 11:10 am
Connect Biopharma
China
eczema
clinical trials
CBP-201
Dupixent
A Pfizer Drug Moves Closer to Approval in Another Important Indication
Motley Fool
Wed, 11/3/21 - 10:38 am
Cibingo
Pfizer
Europe
eczema
atopic dermatitis
AbbVie, Janssen, Novartis, Pfizer and UCB to jointly advance 'digital' endpoint for atopic dermatitis
Endpoints
Tue, 11/2/21 - 10:48 am
atopic dermatitis
eczema
nocturnal scratch
digital endpoint
AbbVie
Janssen
JNJ
Novartis
Pfizer
UCB Pharma
digital pharma
Pages
1
2
3
4
next ›
last »